Every time Rosalie publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
Maybe you’re a closet Clojure or Scala developer, or perhaps you’ve worked with LISP in the past. If so, there’s a good chance you’ve used a REPL as a part of your daily routine. REPL, or ...
Replimune Group, Inc.'s stock has fallen 35% in 2024, and an inflection point is not expected yet. The company is working on RP1, an oncolytic virus therapy, and has shared positive results from their ...
Today’s entrepreneur is Faris Masad, co-founder and CTO of Repl.it. Repl.it’s platform lets users start coding in the programming languages they choose, build and deploy apps right from their browsers ...
The last time I wrote about Replimune Group, Inc. (REPL) it was in a Seeking Alpha article entitled "Replimune: RPL1 BLA Submission Under AA Pathway Makes It A Must Watch." With respect to this ...
Amjad Masad is the co-founder and CEO of Repl.it. Repl.it’s platform lets users to start coding in the programming languages they choose, build and deploy apps right from their browsers. Amjad has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results